v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 27, 2026
Sep. 28, 2025
Cash flows from operating activities    
Net loss $ (50,500) $ (4,400)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment and other charges 200 600
Depreciation and amortization 68,200 60,400
Gain on remeasurement of warrant liability 0 (22,800)
Loss on sale of assets 1,000 700
Loss on debt extinguishment 0 500
Share-based compensation 11,200 12,400
Deferred taxes 1,700 6,100
Deferred financing costs 900 1,000
Changes in assets and liabilities:    
Accounts receivable, net (34,700) (13,400)
Inventories (9,600) (11,500)
Prepaid expenses and other assets 14,200 2,500
Accounts payable and accrued expenses and other (8,000) 15,200
Net cash (used in) provided by operating activities (5,400) 47,300
Cash flows from investing activities    
Purchases of property and equipment (43,500) (89,200)
Proceeds from sale of property and equipment 6,800 900
Proceeds from sale of routes 25,000 17,700
Proceeds from the sale of IO notes 3,300 5,400
Purchases of IO routes and other changes in note receivables (32,000) (30,000)
Net cash used in investing activities (40,400) (95,200)
Cash flows from financing activities    
Borrowings on line of credit 230,000 177,000
Repayments on line of credit (190,000) (156,500)
Borrowings on term debt and notes payable 11,900 81,400
Repayments on term debt and notes payable (26,800) (19,700)
Payment of debt issuance cost 0 (1,700)
Payments of tax withholding requirements for employee stock awards (1,700) (2,200)
Dividends paid (17,400) (16,900)
Distribution to noncontrolling interest (10,500) (11,900)
Net cash (used in) provided by financing activities (4,500) 49,500
Net (decrease) increase in cash and cash equivalents (50,300) 1,600
Cash and cash equivalents at beginning of period 120,400 56,100
Cash and cash equivalents at end of period $ 70,100 $ 57,700